|1.||Lamont, Ronald F: 6 articles (01/2010 - 01/2003)|
|2.||Chauhan, Suneet P: 4 articles (12/2013 - 09/2005)|
|3.||Lubell, William D: 3 articles (07/2015 - 09/2011)|
|4.||Haas, David M: 3 articles (01/2015 - 01/2014)|
|5.||Zimmermann, Roland: 3 articles (04/2014 - 12/2005)|
|6.||Henrich, W: 3 articles (10/2004 - 01/2004)|
|7.||Dudenhausen, J W: 3 articles (10/2004 - 01/2004)|
|8.||Spong, Catherine Y: 2 articles (06/2016 - 04/2006)|
|9.||Mol, Ben Willem J: 2 articles (06/2016 - 01/2009)|
|10.||Claing, Audrey: 2 articles (07/2015 - 09/2011)|
|1.||Premature Obstetric Labor (Premature Labor)
07/01/1999 - "The objective was to perform a systematic review of prospective randomized trials evaluating the efficacy of oral tocolytics in the prevention of recurrent preterm labor and its associated complications. "
10/01/2005 - "Understanding the mechanisms involved may lead to design of tocolytics that target multiple pathways and achieve improved suppression of premature labor."
11/01/1999 - "Although tocolytics prolong pregnancy, they have not been shown to improve perinatal or neonatal outcomes and have adverse effects on women in preterm labor."
07/01/1990 - "The safety and efficacy of tocolytic agents for the treatment of preterm labor."
04/01/1983 - "Natural improvement in the evolution of a disease may lead to exaggerated claims for the benefits of treatment; experience with perinatal death attributed to spontaneous preterm labor in this large unit suggests that current enthusiasm for tocolytic agents may well be misplaced."
|2.||Premature Birth (Birth, Premature)
12/01/1999 - "Once the uterus is quiescent and intravenous tocolytics are stopped, prolonged use of tocolytics has not been shown to be effective in preventing preterm birth. "
07/28/2015 - "On pursuing molecules that delay labour, so-called tocolytics, the prostaglandin F2α receptor (FP) was targeted, because of its role in the stimulation of uterine contractions leading to birth and preterm birth. "
06/01/2015 - "Tocolytic agents can delay preterm birth for at least 2 days, thus allowing the administration of antenatal corticosteroid and in-utero transfer to appropriate neonatal health care settings, interventions that reduce neonatal mortality and morbidity. "
01/01/2015 - "Premature birth is a steadily increasing unmet medical need, for which new "tocolytic" agents are required to arrest contractions and delay labor. "
01/01/2014 - "Preterm birth arising from premature uterine contractions is a major complication of pregnancy and there remains a need to pursue avenues of research that facilitate the use of drugs, tocolytics, to limit these inappropriate contractions without deleterious actions on cardiac electrical excitation. "
03/01/2014 - "Women with successful ECV tolerated side effects of the intervention better than after unsuccessful ECV (pain, tocolytics, mental and physical state, for all p < 0.001). "
07/01/2009 - "The pain was not relieved by the application of tocolytics or mild analgesics. "
11/01/2007 - "The pain was not relieved by the administration of tocolytics or mild analgesics. "
01/01/2014 - "These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. "
01/01/2014 - "Tocolytics for preterm premature rupture of membranes."
01/01/2011 - "Tocolytics for preterm premature rupture of membranes."
03/01/2008 - "[Should tocolytics be used in premature rupture of membranes (PROM)? "
12/01/1991 - "The use of tocolytics in patients with preterm premature rupture of the membranes."
09/01/1988 - "Aggressive early treatment with tocolytic agents in pregnant women with preterm premature membrane rupture is more productive but not more dangerous than conservative management."
11/01/2008 - "[Non-invasive ventilation for pulmonary edema associated with tocolytic agents during labour for a twin pregnancy]."
08/01/2007 - "Of subjects with pulmonary edema 98% received tocolytics while 94% had antenatal corticosteroid therapy versus 50% and 40% in controls. "
01/01/2000 - "[Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents]."
06/01/1991 - "[A female patient with pulmonary edema following administration of beta-sympathicomimetics (tocolytic agents)]."
05/01/2005 - "Risk factors for developing pulmonary edema include: greater MgSO4 and intravenous fluid infusion rates, less concentrated MgSO4, infection, multiple gestations, concomitant tocolytics, large positive net fluid balances, and maternal transport. "
|1.||Analgesics (Analgesic Drugs)
|2.||Anti-Bacterial Agents (Antibiotics)
|6.||Calcium Channel Blockers (Blockers, Calcium Channel)
|8.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|9.||Magnesium Sulfate (Sulfate, Magnesium)
|1.||Bed Rest (Bedrest)
|3.||Cesarean Section (Caesarean Section)
|5.||Neonatal Intensive Care